These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19752640)

  • 1. Reply to letter from Drs. Ledbetter, Saul, and Moeschler.
    Cody J
    Genet Med; 2009 Sep; 11(9):682-3. PubMed ID: 19752640
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on the "genotype first diagnosis" controversy.
    Lacassie Y
    Genet Med; 2009 Sep; 11(9):682. PubMed ID: 19752641
    [No Abstract]   [Full Text] [Related]  

  • 3. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013.
    South ST; Lee C; Lamb AN; Higgins AW; Kearney HM;
    Genet Med; 2013 Nov; 15(11):901-9. PubMed ID: 24071793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How best to use CGH arrays in the clinical setting.
    Saul RA; Moeschler JB
    Genet Med; 2009 May; 11(5):371; author reply 371-2. PubMed ID: 19346958
    [No Abstract]   [Full Text] [Related]  

  • 5. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos.
    Gutiérrez-Mateo C; Colls P; Sánchez-García J; Escudero T; Prates R; Ketterson K; Wells D; Munné S
    Fertil Steril; 2011 Mar; 95(3):953-8. PubMed ID: 20971462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of new genetic technology in investigating autism and developmental delay.
    Shur N; Gunn S; Feit L; Oh AK; Yatchmink Y; Abuelo D
    Med Health R I; 2011 May; 94(5):131, 134-7. PubMed ID: 21710921
    [No Abstract]   [Full Text] [Related]  

  • 7. Special report: aCGH for the genetic evaluation of patients with developmental delay/mental retardation or autism spectrum disorder.
    Technol Eval Cent Assess Program Exec Summ; 2009 Apr; 23(10):1-5. PubMed ID: 19824216
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative genomic hybridisation as a first option in genetic diagnosis: 1,000 cases and a cost-benefit analysis].
    Castells-Sarret N; Cueto-González AM; Borregan M; López-Grondona F; Miró R; Tizzano E; Plaja A
    An Pediatr (Engl Ed); 2018 Jul; 89(1):3-11. PubMed ID: 28958749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical validity of karyotyping for the diagnosis of chromosomal imbalance following array comparative genomic hybridisation.
    Gekas J; Vallée M; Castonguay L; Laframboise R; Maranda B; Piedboeuf B; Rousseau F
    J Med Genet; 2011 Dec; 48(12):851-5. PubMed ID: 21965346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues with the new developmental screening and surveillance policy statement.
    Glascoe FP; Squires J
    Pediatrics; 2007 Apr; 119(4):861-2; discussion 862-3. PubMed ID: 17403863
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel cytogenetic and molecular techniques in the diagnosis of congenital anomalies in newborns.
    Szczałuba K; Śmigiel R
    Dev Period Med; 2015; 19(4):432-40. PubMed ID: 26982750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Child development: pre-screening, screening and super-screening.
    Lingam S
    Indian J Pediatr; 1992; 59(2):139-49. PubMed ID: 1383142
    [No Abstract]   [Full Text] [Related]  

  • 13. Short case report: Xq23 deletion involving PAK3 as a novel cause of developmental delay in a 6-year-old boy.
    Cartwright A; Smith K; Balasubramanian M
    Clin Dysmorphol; 2017 Jan; 26(1):38-40. PubMed ID: 27753653
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of next-generation sequencing on diagnosis and management of neurometabolic disorders: current advances and future perspectives.
    Tarailo-Graovac M; Wasserman WW; Van Karnebeek CD
    Expert Rev Mol Diagn; 2017 Apr; 17(4):307-309. PubMed ID: 28277145
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Choi J; Yoon SY; Park BG; Eun BL; Kim M; Kwon JA
    Ann Lab Med; 2020 May; 40(3):277-280. PubMed ID: 31858772
    [No Abstract]   [Full Text] [Related]  

  • 16. Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children.
    Regier DA; Friedman JM; Makela N; Ryan M; Marra CA
    Clin Genet; 2009 Jun; 75(6):514-21. PubMed ID: 19508416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Molecular Delineation of a Novel De Novo 4q28.3-31.21 Interstitial Deletion in a Patient with Developmental Delay.
    Rim JH; Kim SW; Han SH; Yoo J
    Yonsei Med J; 2015 Nov; 56(6):1742-4. PubMed ID: 26446663
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical utility of molecular karyotyping using high-resolution array-comparative genomic hybridization.
    Tzetis M; Kitsiou-Tzeli S; Frysira H; Xaidara A; Kanavakis E
    Expert Rev Mol Diagn; 2012 Jun; 12(5):449-57. PubMed ID: 22702362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of BACs-on-Beads assay in 1520 cases from Fujian Province, China.
    Wang Y; Zhang M; Chen L; Huang H; Xu L
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1446. PubMed ID: 32767744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive diagnostic value for the clinical features accompanying intellectual disability in children with pathogenic copy number variations: a multivariate analysis.
    Caramaschi E; Stanghellini I; Magini P; Giuffrida MG; Scullin S; Giuva T; Bergonzini P; Guerra A; Paolucci P; Percesepe A
    Ital J Pediatr; 2014 Apr; 40():39. PubMed ID: 24775911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.